Home ›
Trademark Categories ›
Pharmaceuticals ›
2009 ›
QL ›
QLYMB
Trademark search for:
QLYMB
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2009-11-05 — Application filed
2009-11-09 — Application filed
2009-11-13 — Application filed
2009-12-28 — Attorney/dom.rep.revoked and/or appointed
2009-12-28 — Teas revoke/app/change addr of atty/dom rep received
2010-02-10 — Assigned to examiner
2010-02-11 — Final disposition recorded
2010-02-12 — Final disposition recorded
2010-04-16 — Office action issued
2010-05-06 — Approved for pub - principal register
2010-05-06 — Teas/email correspondence entered
2010-05-06 — Assigned to lie
2010-05-06 — Correspondence received in law office
2010-05-06 — Law office publication review completed
2010-05-19 — Notice of publication
2010-06-08 — Published for opposition
2010-08-03 — Noa mailed - sou required from applicant
2011-01-12 — Sou teas extension received
2011-01-12 — Sou extension 1 filed
2011-02-04 — Case assigned to intent to use paralegal
2011-02-04 — Sou extension 1 granted
2011-02-05 — Notice of approval of extension request mailed
2011-04-19 — Attorney/dom.rep.revoked and/or appointed
2011-04-19 — Teas revoke/app/change addr of atty/dom rep received
2011-06-07 — Sou teas extension received
2011-06-07 — Sou extension 2 filed
2011-06-09 — Sou extension 2 granted
2011-06-10 — Notice of approval of extension request mailed
2012-01-19 — Sou teas extension received
2012-01-19 — Sou extension 3 filed
2012-01-23 — Sou extension 3 granted
2012-01-24 — Notice of approval of extension request mailed
2012-07-26 — Sou teas extension received
2012-07-26 — Sou extension 4 filed
2012-08-07 — Sou extension 4 granted
2012-08-08 — Notice of approval of extension request mailed
2013-01-15 — Sou teas extension received
2013-01-15 — Sou extension 5 filed
2013-01-16 — Sou extension 5 granted
2013-01-17 — Notice of approval of extension request mailed
2013-04-03 — Teas change of correspondence received
2013-09-02 — Application abandoned
2013-09-02 — Final status recorded
2013-09-03 — Application abandoned
2014-03-18 — Attorney/dom.rep.revoked and/or appointed
2014-03-18 — Teas revoke/app/change addr of atty/dom rep received
Owner Information
Bristol-Myers Squibb Company
New York , NY
Bristol-Myers Squibb Company
New York , NY
Correspondent
Marc Stanislawczyk AstraZeneca Pharmaceuticals LLP 1800 Concord Pike FOP3-022 Wilmington, DE 19850-5437
Filing Details
Filing Date:
2009-11-05
Status Date:
2013-09-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.